71 results
Page 3 of 4
8-K
EX-99.1
wmfq5r8baiqdu9
9 Nov 21
Annexon Biosciences Announces Business and Program Highlights and Reports Third Quarter 2021 Financial Results
4:16pm
S-3ASR
ezzugj bs6
16 Aug 21
Automatic shelf registration
5:19pm
8-K
EX-99.1
exwvzl0yzduhps6vzc
16 Aug 21
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
4:11pm
8-K
EX-99.1
mztes0tl6fnwq4irw5k6
22 Jul 21
Regulation FD Disclosure
4:15pm
DEF 14A
w7sjc9x39yo7ohp2
22 Apr 21
Definitive proxy
4:06pm
8-K
EX-99.1
my7lbmo6glql4s
25 Mar 21
Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
7:20am
10-K
j996rjqggek gh1cvim
25 Mar 21
Annual report
7:16am
8-K
EX-99.1
je228az9uys1t6bol
11 Jan 21
Regulation FD Disclosure
6:06am
8-K
EX-10.1
xdnpqx6zew8c c7p
22 Dec 20
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
uyapa4xa zlkuqqlvitp
16 Nov 20
Annexon Biosciences Reports Third Quarter 2020 Financial Results and Recent Business Highlights
4:10pm
10-Q
crhui
8 Sep 20
Quarterly report
5:18pm
8-K
EX-3.2
u0svgiz
28 Jul 20
Amendments to Articles of Incorporation or Bylaws
4:21pm
424B4
uzvi 8zvl4k50oh1fdp
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
EX-1.1
x7lhk
20 Jul 20
IPO registration (amended)
6:07am